Telomir Pharmaceuticals Inc (TELO)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	69.46% 1.7647	1.0413	2.1347	1.1465	5.0699
Net Income/Loss	73.73% -1.7215	-0.9909	-2.0612	-1.1023	-5.0699
Preferred Stock Dividends And Other Adjustments	46.11	-	-	-	-
Basic Average Shares	76.95% 60.84	34.38	-	32.40	30.01
Diluted Average Shares	76.95% 60.84	34.38	-	32.40	30.01
Basic Earnings Per Share	2,533% -0.79	-0.03	-	-0.03	0.17
Diluted Earnings Per Share	2,533% -0.79	-0.03	-	-0.03	0.17

CRMD

$7.85

3.09%

DBVT

$9.75

0.72%

CADL

$8.03

4.18%

GYRE

$5.85

0.17%

WVE

$3.18

5.07%

ATTO

$13.83

4.62%